NS
Niraj Shrivastav
About Niraj Shrivastav
Data last updated:
Niraj Shrivastav is a Director at Navsandh Pharma Private Limited (since 2023). The companies operate in Business Services and Information Technology. Navsandh Pharma Private Limited reported revenue of ₹11.1 Lakh (FY 2025). Earlier, Niraj Shrivastav was a Director at Msd Telematics Private Limited (2017–2018).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Navsandh Pharma Private Limited U51100BR2019PTC041671 | Director | 03 Jul 2023 | 2019 | ₹11.1 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Msd Telematics Private Limited U72200DL2011PTC226443 | Director | 30 Jun 2017 | 2011 | ₹16.8 Lakh (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Niraj Shrivastav
| Name | DIN | Company | Designation |
|---|---|---|---|
| Heena Tabssum | 08413315 | Navsandh Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Niraj Shrivastav
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Niraj Shrivastav
Niraj Shrivastav currently holds 1 directorship: Navsandh Pharma Private Limited (Director, since 03 Jul 2023, revenue ₹11.1 Lakh (FY 2025)).
Niraj Shrivastav was first appointed on 30 Jun 2017 as Director at Msd Telematics Private Limited. The most recent appointment on record is 03 Jul 2023 at Navsandh Pharma Private Limited.
Niraj Shrivastav held 1 earlier board appointment: Msd Telematics Private Limited (Director, 30 Jun 2017 to 15 Nov 2018).
The current boards of Niraj Shrivastav's companies include Heena Tabssum (Navsandh Pharma Private Limited).